ArticleOncoimmunology2021

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy.

Duo Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.